H J Dengler. Show Affiliations »
Abstract
Mesh: See more » BiopharmaceuticsBiotransformationDigoxin/bloodDigoxin/metabolismDrug TherapyHumansMetabolic Clearance RateModels, TheoreticalOctopamine/bloodOctopamine/metabolismPhenytoin/bloodPhenytoin/metabolismReceptors, DrugTime Factors
Substances: See more » Receptors, DrugOctopaminePhenytoinDigoxin
Year: 1974 PMID: 4591160
Source DB: PubMed Journal: Internist (Berl) ISSN: 0020-9554 Impact factor: 0.743